Bespoke Extracts, Inc.: Business Overview, Financials & Competitive Analysis
Bespoke Extracts develops and manufactures branded and white-label cannabis products for the regulated U.S. market, with its flagship platform The Joint Company producing pre-rolls and infused products distributed acr...
Cyborg Score thesis
Early-stage Colorado cannabis processor with improving unit economics and margin trajectory, but limited scale, profitability,...
Read the full analyst-debate transcript →Get the Latest Bespoke Extracts, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeBespoke Extracts, Inc. Overview
Pro stress-test →Bespoke Extracts develops and manufactures branded and white-label cannabis products for the regulated U.S. market, with its flagship platform The Joint Company producing pre-rolls and infused products distributed across licensed Colorado dispensaries. The company owns, manufactures, and distributes a diverse portfolio of cannabis consumer packaged goods under the Fresh Joints, Doobskis, DutchBlunts, and Wee Joints brand names.
Strategic Profile
Pro stress-test →The company is scaling Colorado production and pursuing acquisitions to expand its cannabis manufacturing footprint in a capital-constrained but growing regulated market.
Competitive Landscape
Pro stress-test →Bespoke Extracts operates in the Colorado regulated cannabis pre-roll and infused product manufacturing segment, competing with larger, better-capitalized cultivators and CPG brands. The market is fragmented with entrenched players (Trulieve, Cresco Labs via wholesale distribution) and regional brands. Bespoke's differentiation rests on branded direct sales (Fresh Joints, Doobskis) and white-label processing services to licensed dispensaries, but faces margin pressure from scaled competitors and regulatory constraints.
Industry Context
Bespoke Extracts, Inc. operates in Cannabis.
Key facts
Founded: 1988 · Headquarters: Aurora, Colorado, United States · Employees: 2 · Revenue: $1.42M (TTM as of November 2025); 2025 YTD estimated ~$1.50M · Market cap: $3.1M